Nurse Practitioner, Adult Health · Riverhead, NY
NPI
1548694011
Since 2013
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
189 Main Rd
Riverhead, NY, 11901
Phone (631) 288-7120
Groups this clinician bills Medicare through
Medicare paid, 2024
$125K
2,877 services
Medicare patients, 2024
540
Average age 72
Drug cost, 2024
$3.4M
6,308 prescriptions
Company payments, 2025
$1,427
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frederick C Albano was code 99214 (office e&m - established), 1,115 times for 486 patients. In total Frederick C Albano billed 2,877 services in 10 codes, and Medicare paid $125K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,115 | 486 | $88.50 | $99K |
| 82962 Clinical Chemistry | Office | 669 | 276 | $3.17 | $2,123 |
| J0897 Injection, denosumab, 1 mg | Office | 485 | 11 | $20.28 | $9,838 |
| 36415 Venipuncture Blood Collection | Office | 402 | 199 | $8.65 | $3,477 |
| 99203 Office E&M - New | Office | 77 | 77 | $84.49 | $6,506 |
| 95251 Test - Miscellaneous | Office | 71 | 36 | $25.66 | $1,822 |
| 99213 Office E&M - Established | Office | 36 | 35 | $51.49 | $1,854 |
| 96372 Injection Administration | Office | 18 | 15 | $11.11 | $200 |
By year: 2022 $107K for 2,519 services; 2023 $118K for 2,395 services; 2024 $125K for 2,877 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 669 | 276 | $3.17 | $2,123 |
| 36415 Venipuncture Blood Collection | 402 | 199 | $8.65 | $3,477 |
Medicare prescription drug claims, 2024
In 2024, the drug Frederick C Albano prescribed most often to Medicare patients was Levothyroxine Sodium, with 716 prescriptions and refills. In total Frederick C Albano wrote 6,308 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 716 | 1,541 | 172 | $9,686 |
| Metformin Hcl Er Metformin Hcl | 506 | 1,401 | 166 | $6,520 |
| Pioglitazone Hcl Generic | 318 | 841 | 92 | $4,134 |
| Synthroid Levothyroxine Sodium | 299 | 812 | 77 | $24K |
| Ozempic Semaglutide | 291 | 617 | 89 | $572K |
| Metformin Hcl Generic | 283 | 738 | 85 | $2,189 |
| Trulicity Dulaglutide | 262 | 539 | 80 | $515K |
| Glimepiride Generic | 227 | 673 | 72 | $2,045 |
| Mounjaro Tirzepatide | 217 | 370 | 64 | $390K |
| Farxiga Dapagliflozin Propanediol | 196 | 494 | 62 | $268K |
| Jardiance Empagliflozin | 186 | 402 | 52 | $226K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 181 | 450 | 73 | $34K |
| Januvia Sitagliptin Phosphate | 174 | 412 | 51 | $221K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 168 | 486 | 79 | $15K |
| Tradjenta Linagliptin | 114 | 270 | 32 | $131K |
Brand drugs: 2,942 claims; generic drugs: 2,991 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frederick C Albano $1,427 ($1,427 in general payments such as food, travel and fees) from 18 companies. The largest payer was Dexcom, Inc. with $248.
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. DXCM | 3 | $248 |
| Medtronic, Inc. MDT | 8 | $149 |
| Ascendis Pharma Endocrinology Inc ASND | 1 | $124 |
| Novo Nordisk Inc NVO | 6 | $120 |
| Abbvie Inc. ABBV | 5 | $105 |
| CeQur Corporation | 1 | $101 |
| Recordati_rare_diseases_inc. | 4 | $96.98 |
| Xeris Pharmaceuticals, Inc. | 5 | $96.98 |
| Abbott Laboratories ABT | 4 | $77.48 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $76.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.